AAAAAA
Results: 1-25/36
Authors:
Yang, Y
Grosset, DG
Yang, T
Lees, KR
Citation: Y. Yang et al., Characterization of ultrasound-detected cerebral microemboli in patients undergoing cardiac catheterization using an in vitro middle cerebral artery model, CATHET C IN, 53(3), 2001, pp. 323-330
Authors:
Lees, KR
Lavelle, JF
Cunha, L
Diener, HC
Sanders, EACM
Tack, P
Wester, P
Citation: Kr. Lees et al., Glycine antagonist (GV150526) in acute stroke: A multicentre, double-blindplacebo-controlled phase II trial, CEREB DIS, 11(1), 2001, pp. 20-29
Authors:
Albers, GW
Bogousslavsky, J
Bozik, MA
Brass, LM
Broderick, JP
Fisher, M
Goldstein, LB
Salazar-Grueso, E
Akitsuki, S
Aranko, K
Ashwood, T
Atkinson, RP
Bell, RD
Brott, TG
Cady, WJ
Caplan, LR
Coggins, S
Cramer, S
Cyrus, P
Dayno, J
Easton, JD
Elliott, PJ
Finklestein, SP
Furlan, AJ
Gamzu, E
Glasky, MS
Gordon, K
Gorelick, PB
Greenwood, DT
Grotta, JC
Gunn, K
Hachinski, V
Hacke, W
Hall, ED
Hsu, CY
Humphreys, DM
Ishikawa, H
Jacobs, AJ
Kaste, M
Koroshetz, WJ
Krams, M
Lauritano, AA
Leclerc, J
Lees, KR
Lesko, L
Levine, SR
Levy, DE
Li, FH
Lyden, PD
Masayasu, H
McDermott, J
Meibach, RC
Meya, U
Miyairi, K
Niidome, T
Oeda, J
Poole, RM
Ron, ES
Sacco, RL
Saltarelli, MD
Shimizu, K
Shook, BJ
Soehngen, M
Soehngen, W
Stamler, DA
Styren, SD
Teal, PA
Tilley, BC
Traystman, RJ
Walker, MD
Wallin, BA
Warach, S
Ward, DP
Wessel, TC
Wettstein, J
Citation: Gw. Albers et al., Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II), STROKE, 32(7), 2001, pp. 1598-1606
Authors:
Bath, P
Boysen, G
Donnan, G
Kaste, M
Lees, KR
Olsen, T
Overgaard, K
Sandercock, P
Wahlgren, NG
Citation: P. Bath et al., Hypertension in acute stroke: What to do?, STROKE, 32(7), 2001, pp. 1697-1698
Authors:
Lees, KR
Sharma, AK
Barer, D
Ford, GA
Kostulas, V
Cheng, YF
Odergren, T
Citation: Kr. Lees et al., Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke, STROKE, 32(3), 2001, pp. 675-680
Authors:
Lees, KR
Dyker, AG
Sharma, A
Ford, GA
Ardron, ME
Grosset, DG
Citation: Kr. Lees et al., Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients - A dose-ranging study, STROKE, 32(2), 2001, pp. 466-472
Authors:
Walters, MR
Bolster, A
Dyker, AG
Lees, KR
Citation: Mr. Walters et al., Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease, STROKE, 32(2), 2001, pp. 473-478
Authors:
Lees, KR
Dyker, AG
Sharma, A
Ford, GA
Ardron, ME
Grosset, DG
Citation: Kr. Lees et al., Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients: A dose-ranging study (vol 32, pg 466, 2001), STROKE, 32(12), 2001, pp. 2961-2961
Authors:
Weir, CJ
McCarron, MO
Muir, KW
Dyker, AG
Bone, I
Lees, KR
Nicoll, JAR
Citation: Cj. Weir et al., Apolipoprotein E genotype, coagulation, and survival following acute stroke, NEUROLOGY, 57(6), 2001, pp. 1097-1100
Authors:
Lees, KR
Citation: Kr. Lees, Advances in neuroprotection trials, EUR NEUROL, 45(1), 2001, pp. 6-10
Authors:
Overell, JR
Lees, KR
Bone, I
Citation: Jr. Overell et al., Percutaneous closure of patent foramen ovale in patients with paradoxical embolism, CIRCULATION, 103(10), 2001, pp. E56-E56
Authors:
Muir, KW
Watt, A
Baxter, G
Grosset, DG
Lees, KR
Citation: Kw. Muir et al., Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke, QJM-MON J A, 93(6), 2000, pp. 359-364
Authors:
Muir, KW
Holzapfel, L
Lees, KR
Citation: Kw. Muir et al., Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke, CEREB DIS, 10(6), 2000, pp. 431-436
Authors:
Lees, KR
Bath, PMW
Naylor, AR
Citation: Kr. Lees et al., ABC of arterial and venous disease - Secondary prevention of transient ischaemic attack and stroke, BR MED J, 320(7240), 2000, pp. 991-994
Authors:
Bath, PHW
Lees, KR
Citation: Phw. Bath et Kr. Lees, ABC of arterial and venous disease - Acute stroke, BR MED J, 320(7239), 2000, pp. 920-923
Authors:
Lees, KR
Asplund, K
Carolei, A
Davis, SM
Diener, HC
Kaste, M
Orgogozo, JM
Whitehead, J
Citation: Kr. Lees et al., Glycine antagonist (gavestinel) in neuroprotection (GAIN International) inpatients with acute stroke: a randomised controlled trial, LANCET, 355(9219), 2000, pp. 1949-1954
Authors:
Overell, JR
Weir, CJ
Walker, A
Lees, KR
Citation: Jr. Overell et al., Treatment and secondary prevention of stroke, LANCET, 355(9200), 2000, pp. 319-320
Authors:
Lees, KR
Bath, PMW
Naylor, AR
Citation: Kr. Lees et al., Secondary prevention of transient ischemic attack and stroke, WEST J MED, 173(4), 2000, pp. 254-258
Authors:
Bath, PMW
Lees, KR
Citation: Pmw. Bath et Kr. Lees, Acute stroke, WEST J MED, 173(3), 2000, pp. 209-212
Authors:
Cornu, C
Boutitie, F
Candelise, L
Boissel, JP
Donnan, GA
Hommel, M
Jaillard, A
Lees, KR
Citation: C. Cornu et al., Streptokinase in acute ischemic stroke: An individual patient data meta-analysis - The Thrombolysis in Acute Stroke Pooling Project, STROKE, 31(7), 2000, pp. 1555-1560
Authors:
Yang, Y
Grosset, DG
Li, Q
Lees, KR
Citation: Y. Yang et al., Identification of echocardiographic "smoke" in a bench model with transcranial Doppler ultrasound, STROKE, 31(4), 2000, pp. 907-914
Authors:
Davis, SM
Lees, KR
Albers, GW
Diener, HC
Markabi, S
Karlsson, G
Norris, J
Citation: Sm. Davis et al., Selfotel in acute ischemic stroke - Possible neurotoxic effects of an NMDAantagonist, STROKE, 31(2), 2000, pp. 347-354
Authors:
Hoke, JF
Dyker, AG
Barnaby, RJ
Lees, KR
Citation: Jf. Hoke et al., Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke, EUR J CL PH, 55(11-12), 2000, pp. 867-872
Authors:
Overell, JR
Bone, I
Lees, KR
Citation: Jr. Overell et al., Interatrial septal abnormalities and stroke - A meta-analysis of case-control studies, NEUROLOGY, 55(8), 2000, pp. 1172-1179
Authors:
Cummings, ML
Evans, JG
Ferns, ML
Lees, KR
Citation: Ml. Cummings et al., Stratigraphic and structural evolution of the middle Miocene synvolcanic Oregon-Idaho graben, GEOL S AM B, 112(5), 2000, pp. 668-682